Immp2l Deficiency Aggravates Traumatic Brain Injury Through Mitochondria-Mediated Apoptotic Pathways
Acta Poloniae Pharmaceutica - Drug Research · 04.10.2026 · 83 (3) · 383-399
DOI: 10.32383/appdr/231277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Poloniae Pharmaceutica - Drug Research, online erschienen am 04.10.2026. Verfasst von Nan Cao und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Traumatic brain injury (TBI) continues to pose a major worldwide health burden, a condition characterized by secondary neuronal damage in which mitochondrial dysfunction constitutes a key mechanism. The inner mitochondrial membrane peptidase 2-like (Immp2l) gene, known to be involved in oxidative stress regulation, but its role in TBI pathogenesis remains unclear.
Methods
Male wild-type mice (WT; Immp2l^+/+) and homozygous Immp2l insertional mutant mice [Immp2l^Tg(Tyr)979Ove/Tg(Tyr)979Ove] aged 3–4 months were subjected to traumatic brain injury using the controlled cortical impact model. Neurological deficits, brain water content, and histopathological alterations were assessed. Oxidative stress and mitochondrial function were evaluated by measuring ATP, SOD1/2, ROS, MDA, and MPO levels. Expression of apoptosis-related proteins, including cleaved caspase-3, cytochrome c (Cyt c), poly(ADP-ribose) polymerase-1 (Parp-1), apoptosis-inducing factor (AIF), Bcl-2, and Bax, was examined via immunohistochemistry and Western blotting. The mitochondrial permeability transition pore inhibitor NIM811 (10 mg/kg) was administered to assess neuroprotective effects.
Results
The homozygous Immp2l insertional mutation aggravated TBI-induced neurological deficits and brain edema. Compared with WT mice, Immp2l mutant mice exhibited reduced ATP levels, SOD1/2 activity, and mitochondrial membrane potential, together with increased ROS, MDA, and MPO levels after TBI. Administration of NIM811 attenuated cortical apoptosis and reduced the expression of mitochondria-associated apoptotic mediators.
Conclusion
In TBI, Immp2l serves a neuroprotective function, which involves safeguarding mitochondrial homeostasis and blocking apoptosis. This positions Immp2l-mediated mitochondrial signaling as a potential target for developing therapeutic interventions against TBI.
Zitieren
APA
Cao, N., Xu, J., Qi, N., Dong, Y., Tang, F., Wang, Z., Jin, X., Shi, H., Zhang, Z., & Duan, Y. (2026). Immp2l Deficiency Aggravates Traumatic Brain Injury Through Mitochondria-Mediated Apoptotic Pathways. Acta Poloniae Pharmaceutica - Drug Research, 83(3), 383-399. https://doi.org/10.32383/appdr/231277
Vancouver
Cao N, Xu J, Qi N, Dong Y, Tang F, Wang Z, et al. Immp2l Deficiency Aggravates Traumatic Brain Injury Through Mitochondria-Mediated Apoptotic Pathways. Acta Poloniae Pharmaceutica - Drug Research. 2026;83(3):383-399. doi:10.32383/appdr/231277
BibTeX
@article{Cao2026,
author = {Cao, Nan and Xu, Jie and Qi, Ning and Dong, Yixiao and Tang, Feng and Wang, Zhengliang and Jin, Xin and Shi, Hong and Zhang, Zhao and Duan, Yu},
title = {Immp2l Deficiency Aggravates Traumatic Brain Injury Through Mitochondria-Mediated Apoptotic Pathways},
journal = {Acta Poloniae Pharmaceutica - Drug Research},
year = {2026},
volume = {83},
number = {3},
pages = {383--399},
doi = {10.32383/appdr/231277}
}
EUVIMED